Concerns Regarding Use of High-Dose Cyclosporine in the Management of Refractory Chronic Spontaneous Urticaria.
作者信息
Santhosh Parvathy, Khan Sujoy
机构信息
Department of Clinical Immunology and Allergy, Castle Hill Hospital, Cottingham, United Kingdom.
出版信息
Indian Dermatol Online J. 2025 Apr 15;16(4):693-694. doi: 10.4103/idoj.idoj_1274_24. eCollection 2025 Jul-Aug.
Abstract
摘要
相似文献
1
Concerns Regarding Use of High-Dose Cyclosporine in the Management of Refractory Chronic Spontaneous Urticaria.关于在难治性慢性自发性荨麻疹管理中使用高剂量环孢素的担忧。
Indian Dermatol Online J. 2025 Apr 15;16(4):693-694. doi: 10.4103/idoj.idoj_1274_24. eCollection 2025 Jul-Aug.
2
Use of nonbiologic treatments in antihistamine-refractory chronic urticaria: a review of published evidence.抗组胺药难治性慢性荨麻疹的非生物治疗应用：已发表证据综述
J Dermatolog Treat. 2018 Feb;29(1):80-97. doi: 10.1080/09546634.2017.1329505. Epub 2017 May 31.
3
Impact of Pharmacological Treatments for Chronic Spontaneous Urticaria with an Inadequate Response to H1-Antihistamines on Health-Related Quality of Life: A Systematic Review and Network Meta-Analysis.抗组胺药治疗慢性自发性荨麻疹疗效不佳患者的药物治疗对健康相关生活质量的影响：系统评价和网络荟萃分析。
J Allergy Clin Immunol Pract. 2022 Jan;10(1):297-308. doi: 10.1016/j.jaip.2021.10.022. Epub 2021 Oct 22.
4
Comparative efficacy and safety of biologics and systemic immunomodulatory treatments for chronic urticaria: Systematic review and network meta-analysis.生物制剂和全身免疫调节治疗慢性荨麻疹的疗效和安全性比较：系统评价和网状Meta分析
J Allergy Clin Immunol. 2025 Jul 11. doi: 10.1016/j.jaci.2025.06.004.
5
Response to Letter to the Editor: Addressing Concerns Regarding High-Dose Cyclosporine in Chronic Spontaneous Urticaria.致编辑的信的回复：解决关于慢性自发性荨麻疹中高剂量环孢素的担忧。
Indian Dermatol Online J. 2025 May 26;16(4):695-696. doi: 10.4103/idoj.idoj_156_25. eCollection 2025 Jul-Aug.
6
Omalizumab in pediatric chronic spontaneous urticaria: A systematic review and meta-analysis of efficacy and safety.奥马珠单抗治疗儿童慢性自发性荨麻疹：疗效与安全性的系统评价和荟萃分析
Pediatr Allergy Immunol. 2025 Jun;36(6):e70132. doi: 10.1111/pai.70132.
7
The Efficacy of Different Dosing Regimens of Omalizumab in Children and Adolescents with Chronic Spontaneous Urticaria Based on Real-Life Data.基于真实生活数据的奥马珠单抗不同给药方案对儿童和青少年慢性自发性荨麻疹的疗效
Int Arch Allergy Immunol. 2025 Jun 4:1-10. doi: 10.1159/000545336.
8
Comparison between chronic spontaneous urticaria and chronic induced urticaria on the efficacy of omalizumab treatment: A systematic review and meta-analysis.慢性自发性荨麻疹与慢性诱导性荨麻疹在奥马珠单抗治疗效果方面的比较：系统评价和荟萃分析。
Dermatol Ther. 2022 Dec;35(12):e15928. doi: 10.1111/dth.15928. Epub 2022 Oct 26.
9
H1-antihistamines for chronic spontaneous urticaria: an abridged Cochrane Systematic Review.H1 抗组胺药治疗慢性自发性荨麻疹：Cochrane 系统评价摘要。
J Am Acad Dermatol. 2015 Oct;73(4):710-716.e4. doi: 10.1016/j.jaad.2015.06.048. Epub 2015 Aug 5.
10
Rilzabrutinib in Antihistamine-Refractory Chronic Spontaneous Urticaria: The RILECSU Phase 2 Randomized Clinical Trial.利扎布替尼治疗抗组胺药难治性慢性自发性荨麻疹：RILECSU 2期随机临床试验
JAMA Dermatol. 2025 Apr 23. doi: 10.1001/jamadermatol.2025.0733.
本文引用的文献
1
Real-World Clinical Experience with Oral Cyclosporine in Antihistamine Refractory Cases of Chronic Spontaneous Urticaria.口服环孢素治疗抗组胺药难治性慢性自发性荨麻疹的真实世界临床经验
Indian Dermatol Online J. 2024 Jul 15;15(5):887-890. doi: 10.4103/idoj.idoj_745_23. eCollection 2024 Sep-Oct.
2
Role of Cyclosporine (CsA) in Immuno-dermatological Conditions.环孢素（CsA）在免疫性皮肤病中的作用。
Indian Dermatol Online J. 2022 Sep 5;13(5):585-599. doi: 10.4103/idoj.idoj_189_22. eCollection 2022 Sep-Oct.
3
British Association of Dermatologists guidelines for the management of people with chronic urticaria 2021.英国皮肤科医师协会2021年慢性荨麻疹患者管理指南。
Br J Dermatol. 2022 Mar;186(3):398-413. doi: 10.1111/bjd.20892. Epub 2022 Jan 27.
4
British Association of Dermatologists guidelines for the safe and effective prescribing of oral ciclosporin in dermatology 2018.英国皮肤科医师协会2018年皮肤科口服环孢素安全有效处方指南。
Br J Dermatol. 2019 Jun;180(6):1312-1338. doi: 10.1111/bjd.17587. Epub 2019 Apr 7.
5
Consensus Statement for the Diagnosis and Treatment of Urticaria: A 2017 Update.《荨麻疹诊断和治疗的共识声明：2017年更新版》
Indian J Dermatol. 2018 Jan-Feb;63(1):2-15. doi: 10.4103/ijd.IJD_308_17.
Zotero 插件